Now, here is a creative idea. Using antibodies, originated in goose, to treat canine parvovirus.
Presently, this is an experimental treatment.
But ongoing trials are showing reduction of mortality from canine parvovirus to 15%, with an average hospitalization of two days.
With supportive care, which is the only treatment presently available, the mortality is about 50%.
This would be the first actual treatment for parvo. Parvovirus primarily infects young puppies before they receive their full vaccinations, or dogs that have not been vaccinated.
A few months ago it was first used on puppies rescued from a puppy mill and one adult dog.
Avianax, the company working on the treatment, now has USDA permit to ship it to veterinarians who will use it in a field trial.
Considering how devastating parvo infection is, this is an exciting development to watch.
Goose antibodies that can save puppies
New Test For Emerging Strains Of Parvovirus
Viral Infections: Cosmo's Battle with Parvovirus
Parvo: Cora's Story